Becattini, L.; Saieva, C.; Doni, L.; Roviello, G.; Spatafora, P.; Catalano, M.; Sessa, F.; Galli, I.C.; Bisegna, C.; Conte, F.L.;
et al. Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy. Medicina 2022, 58, 886.
https://doi.org/10.3390/medicina58070886
AMA Style
Becattini L, Saieva C, Doni L, Roviello G, Spatafora P, Catalano M, Sessa F, Galli IC, Bisegna C, Conte FL,
et al. Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy. Medicina. 2022; 58(7):886.
https://doi.org/10.3390/medicina58070886
Chicago/Turabian Style
Becattini, Lucrezia, Calogero Saieva, Laura Doni, Giandomenico Roviello, Pietro Spatafora, Martina Catalano, Francesco Sessa, Ilaria Camilla Galli, Claudio Bisegna, Francesco Lupo Conte,
and et al. 2022. "Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy" Medicina 58, no. 7: 886.
https://doi.org/10.3390/medicina58070886
APA Style
Becattini, L., Saieva, C., Doni, L., Roviello, G., Spatafora, P., Catalano, M., Sessa, F., Galli, I. C., Bisegna, C., Conte, F. L., Zaccaro, C., Santi, R., Serni, S., Nesi, G., & Villari, D.
(2022). Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy. Medicina, 58(7), 886.
https://doi.org/10.3390/medicina58070886